The CADDRA Canadian ADHD medication chart is now available in a bilingual Canada-wide format (latest update November 2022).  Healthcare professionals may find the chart useful when discussing medication with individuals with ADHD and their families.

The chart provides information on ADHD medications available in Canada, including names and full colour illustrations of the medications. The chart indicates whether products are recommended  as first or second line treatments by CADDRA, and show starting dose, duration of action, delivery,  release mode and indicate dose titration per product monograph. Click here for an online overview of formulary-based access to ADHD medications across Canada.

Laminated versions of the medication charts are included with every copy of the Canadian ADHD Practice Guidelines,  which are provided without cost to CADDRA members or can be ordered from the CADDRA office by non-members.

*Please note this downloadable resource is provided for individual use only. Reproduction requests should be sent to